20180228_OPR_OR, Logos _BIZ_WD_neutrolis-Logo (1).jpg
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
23 déc. 2024 08h00 HE | Neutrolis, Inc.
CAMBRIDGE, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) for the treatment of autoimmune and...
Surrozen Logo FINAL Large-1.png
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
09 mai 2024 08h30 HE | Surrozen, Inc.
Surrozen Presents Data Demonstrating the Promise of Antibody Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at ARVO 2024
Surrozen Logo FINAL Large-1.png
Surrozen Provides First Quarter 2024 Financial Results and Business Update
08 mai 2024 16h05 HE | Surrozen, Inc.
Surrozen Provides First Quarter 2024 Financial Results and Business Update
Verana+logo+horizontal.jpg
Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kind
04 avr. 2024 09h00 HE | Verana Health, Inc.
SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today...
VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
27 mars 2024 09h00 HE | AXIM Biotechnologies, Inc.
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire...
Transparency Market Research
Dry Eye Disease Market Size Projected to Reach USD 8.7 billion by 2031, With 4.2% CAGR: Transparency Market Research, Inc.
04 janv. 2024 10h00 HE | Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The dry eye disease was worth US$ 6.1 billion in 2022. In 2031, it is predicted that the...
Logo.png
Dry Eye Disease Market to Register Immense Growth During the Study Period (2019–2032), Estimates DelveInsight | Leading Companies - BRIM, Ocular, Iacta, AbbVie, Novartis, Kowa, Sylentis, Palatin, Yuyu, Mimetogen
07 déc. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Dry Eye Disease Market to Register Immense Growth During the Study Period (2019–2032), Estimates DelveInsight | Leading Companies - BRIM, Ocular,...
merakris_logo_4color copy.jpg
Merakris Announces Nationwide At-Your-Door Autologous Serum Tears Program
12 oct. 2023 06h30 HE | Merakris Therapeutics
The Opticyte Tears program uses patients’ blood serum to create Autologous Serum Tears from the convenience of their homes.
AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
12 juil. 2023 09h00 HE | AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform SAN DIEGO, CA, July 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire  –...
The Dry Eye Drink by Bruder
Bruder Healthcare Now Exclusive Licensor of the Dry Eye Drink™ -- First and Only Ophthalmic Anti-Inflammatory Hyper-Hydrating Drink
13 févr. 2023 10h00 HE | Bruder Healthcare
ATLANTA, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Bruder Healthcare, a Hilco Vision Company, announced an exclusive licensing agreement with Baton Rouge-based Dry Eye Drink LLC, the manufacturer of a...